Finance

Lists
Why is INCR down 6,76%?
Dive Deeper
INCR:NASDAQ
InterCure Ltd
USD 4,69
-6,76%
(-0,34) 1D
14 Okt., 13:39:52 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for INCR...
Open
USD 4,80
High
USD 4,98
Low
USD 4,67
Mkt. cap
224,18 m
Avg. vol.
6,08 k
Volume
8,86 k
52-wk high
USD 8,16
52-wk low
USD 3,40
Beta
1,43
Shares outstanding
11,85 m
No. of employees
285
Open
USD 4,80
High
USD 4,98
Low
USD 4,67
Mkt. cap
224,18 m
Avg. vol.
6,08 k
Volume
8,86 k
52-wk high
USD 8,16
52-wk low
USD 3,40
Beta
1,43
Shares outstanding
11,85 m
No. of employees
285
News stories
From web sources and news partners
About InterCure Ltd
CEOAlexander Rabinovitch
Employees285
Founded1994
Headquarters-
SectorPharmaceutical industry
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in ILS
Mrt. 2025
Jun. 2025
Sep. 2025
Des. 2025
Revenue
65,01 m
65,01 m
70,09 m
70,09 m
Cost of goods sold
44,89 m
44,89 m
69,86 m
69,86 m
Cost of revenue
44,89 m
44,89 m
69,86 m
69,86 m
Research and development expenses
95,50 k
95,50 k
99,50 k
99,50 k
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
20,21 m
20,21 m
26,49 m
26,49 m
Operating expense
17,21 m
17,21 m
36,76 m
36,76 m
Total operating expenses
62,11 m
62,11 m
106,61 m
106,61 m
Operating income
2,90 m
2,90 m
-36,52 m
-36,52 m
Other non operating income
-
-
-85,50 k
-85,50 k
EBT including unusual items
-1,15 m
-1,15 m
-20,90 m
-20,90 m
EBT excluding unusual items
-1,11 m
-1,11 m
-40,80 m
-40,80 m
Income tax expense
-242,50 k
-242,50 k
-3,42 m
-3,42 m
Effective tax rate
21,11%
21,11%
16,35%
16,35%
Other operating expenses
-3,53 m
-3,53 m
9,40 m
9,40 m
Net income
-852,00 k
-852,00 k
-17,00 m
-17,00 m
Net profit margin
-1,31%
-1,31%
-24,26%
-24,26%
Earnings per share
-
-
-
-
Interest and investment income
1,18 m
1,18 m
-
-
Interest expense
-5,18 m
-5,18 m
-5,05 m
-5,05 m
Net interest expenses
-4,01 m
-4,01 m
-5,05 m
-5,05 m
Depreciation and amortization charges
-
-
-
-
EBITDA
7,12 m
7,12 m
-34,80 m
-34,80 m
Gain or loss from assets sale
-
-
1,63 m
1,63 m
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google-programme